Longevity Acquisition Corporation
(NASDAQ GS: LOAC)
Rigrodsky Law, P.A. is investigating Longevity Acquisition Corporation (“Longevity”) regarding possible breaches of fiduciary duties and other violations of law related to Longevity's agreement to merge with 4D Pharma PLC ("4D Pharma"). Under the terms of the agreement, Longevity’s shareholders will receive 7.5315 ordinary shares of 4D Pharma for each share of Longevity they own.